Beyond PD-1, a combination of anti-TIGIT or anti-KLRG1 antibodies and DNA methyltransferase inhibitor reversed the metastasis-promoting state acquired by certain tumor-exposed NK cells [147]. The gene discussed is KLRG1; the disease is neoplasm.